MarketScreener Editorial Features Gan & Lee Pharmaceuticals.

Stocks

End-of-day quote Shanghai S.E. Other stock markets 2026-06-12			5-day change	1st Jan Change
55.62 ^CNY	-0.34%		+1.91%	-18.29%

Jun. 12	Gan & Lee Pharmaceuticals Reports Positive Clinical Results for Insulin Ludefen and Bofanglutide	CI
May. 15	Sandoz Group AG Confirms European Commission Approval for Biosimilars Bysumlog® (Insulin Lispro) and Dazparda® (Insulin Aspart), Strengthening Position in Diabetes	CI